AU2001250572A1 - Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations - Google Patents

Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations

Info

Publication number
AU2001250572A1
AU2001250572A1 AU2001250572A AU5057201A AU2001250572A1 AU 2001250572 A1 AU2001250572 A1 AU 2001250572A1 AU 2001250572 A AU2001250572 A AU 2001250572A AU 5057201 A AU5057201 A AU 5057201A AU 2001250572 A1 AU2001250572 A1 AU 2001250572A1
Authority
AU
Australia
Prior art keywords
methylations
snp
cytosine
detection
single nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001250572A
Inventor
Kurt Berlin
Alexander Olek
Christian Piepenbrock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epigenomics AG
Original Assignee
Epigenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenomics AG filed Critical Epigenomics AG
Publication of AU2001250572A1 publication Critical patent/AU2001250572A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
AU2001250572A 2000-04-07 2001-04-06 Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations Abandoned AU2001250572A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10019173 2000-04-07
DE10019173.8 2000-04-07
PCT/IB2001/000713 WO2001077384A2 (en) 2000-04-07 2001-04-06 Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations

Publications (1)

Publication Number Publication Date
AU2001250572A1 true AU2001250572A1 (en) 2001-10-23

Family

ID=7639166

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001250572A Abandoned AU2001250572A1 (en) 2000-04-07 2001-04-06 Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations

Country Status (4)

Country Link
US (1) US20040241651A1 (en)
EP (1) EP1268856A2 (en)
AU (1) AU2001250572A1 (en)
WO (1) WO2001077384A2 (en)

Families Citing this family (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262249B1 (en) * 1998-06-23 2001-07-17 Chiron Corporation Pancreatic cancer genes
DE10048091A1 (en) * 2000-09-28 2002-04-25 Ernst Bayer Use of chemically modified oligodeoxyribonucleotides to suppress the proliferation of human pancreatic tumors
US7612194B2 (en) * 2001-07-24 2009-11-03 Monsanto Technology Llc Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof
US6964950B2 (en) * 2001-07-25 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of C-reactive protein expression
US7425545B2 (en) * 2001-07-25 2008-09-16 Isis Pharmaceuticals, Inc. Modulation of C-reactive protein expression
US7888324B2 (en) 2001-08-01 2011-02-15 Genzyme Corporation Antisense modulation of apolipoprotein B expression
US7407943B2 (en) 2001-08-01 2008-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein B expression
US7176303B2 (en) * 2003-11-06 2007-02-13 Isis Pharmaceuticals, Inc. Modulation of STAT5 expression
CA2473082A1 (en) * 2002-01-18 2003-07-24 Genomar Asa Verification of fish origin based on nucleic acid pattern recognition
US20030215842A1 (en) * 2002-01-30 2003-11-20 Epigenomics Ag Method for the analysis of cytosine methylation patterns
JP2003289869A (en) * 2002-04-02 2003-10-14 Tosoh Corp Oligonucleotide for assaying mycobacterium avium as atypical acid-fast bacterium, and method for detecting the same
NZ536414A (en) * 2002-05-06 2007-11-30 Genesis Res & Dev Corp Ltd Dihydroflavonal-4-reductase (DFR) sequences from Festuca arundinacea and Lolium perenne
ES2316501T3 (en) * 2002-05-21 2009-04-16 Mtm Laboratories Ag MARKER MOLECULES ASSOCIATED WITH PULMONARY TUMORS.
US7199107B2 (en) 2002-05-23 2007-04-03 Isis Pharmaceuticals, Inc. Antisense modulation of kinesin-like 1 expression
JPWO2003100057A1 (en) * 2002-05-28 2005-09-22 独立行政法人産業技術総合研究所 Chemical sensor system
JP2004016054A (en) * 2002-06-13 2004-01-22 Takara Bio Inc Method for localizing polypeptide on cell surface
AU2003247303A1 (en) * 2002-07-17 2004-02-02 Index Pharmaceuticals Ab Antisense compounds, methods and compositions for treating ngal-related inflammatory disorders
EP1403384A1 (en) * 2002-09-26 2004-03-31 Stichting Researchfonds Pathologie Method for detecting and typing of cutaneous HPV and primers and probes for use therein
JP2006500067A (en) * 2002-09-26 2006-01-05 エフ　エム　シー　コーポレーション Hemipteran myosin light chain kinase
US20060009410A1 (en) * 2002-11-13 2006-01-12 Crooke Rosanne M Effects of apolipoprotein B inhibition on gene expression profiles in animals
US7511131B2 (en) 2002-11-13 2009-03-31 Genzyme Corporation Antisense modulation of apolipoprotein B expression
US7144999B2 (en) * 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
US7468248B2 (en) 2002-12-31 2008-12-23 Cargill, Incorporated Methods and systems for inferring bovine traits
MXPA05008143A (en) * 2003-01-31 2006-03-09 Monsanto Technology Llc Glyphosate tolerant alfalfa events and methods for detection thereof.
US7846906B2 (en) 2003-02-28 2010-12-07 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
US7803781B2 (en) * 2003-02-28 2010-09-28 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
BRPI0412419A (en) * 2003-07-10 2006-08-22 Akzo Nobel Nv babesia protein, nucleic acid, cdna fragment, recombinant DNA molecule, recombinant living vehicle, host cell, vaccine, method for preparing a vaccine, use of a protein or immunogenic fragment of said protein, and diagnostic tests for detecting a nucleic acid associated with, for detecting antibodies against, and for detecting antigenic material in an organism of the babesiidae family
ES2289544T3 (en) * 2003-08-12 2008-02-01 Antisense Pharma Gmbh OLIGONUCLEOTIDO ANTISENTIDO TO INHIBIT THE INHIBITING ACTIVITY OF MELANOMA MIA.
WO2005033284A2 (en) * 2003-10-01 2005-04-14 The Regents Of The University Of California Compositions and methods for gene expression
WO2005040426A1 (en) * 2003-10-27 2005-05-06 Fnp Corp., Ltd. Molecular marker associated with cmv resistance and use thereof
AU2004295712B2 (en) * 2003-12-01 2011-05-19 Epigenomics Ag Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
EP2363480A3 (en) * 2004-01-20 2015-10-07 Isis Pharmaceuticals, Inc. Modulation of glucocorticoid receptor expression
US7297785B2 (en) * 2004-03-24 2007-11-20 United States Of America As Represented By The Secretary Of The Army Unique chromosomal sequence of Bacillus anthracis and methods of making and using thereof including real-time PCR assays
AU2005229157B2 (en) * 2004-03-31 2011-07-21 Commonwealth Scientific And Industrial Research Organisation Genes involved in plant fibre development
AU2005244258B2 (en) 2004-04-09 2010-07-01 Monsanto Technology Llc Compositions and methods for control of insect infestations in plants
US7365058B2 (en) 2004-04-13 2008-04-29 The Rockefeller University MicroRNA and methods for inhibiting same
US20050287558A1 (en) * 2004-05-05 2005-12-29 Crooke Rosanne M SNPs of apolipoprotein B and modulation of their expression
ATE499614T1 (en) * 2004-05-24 2011-03-15 Anamar Ab METHOD FOR DETERMINING A TISSUE DEGRADATION PROCESS BY DETECTING COMP-NEOEPITOPES
GB2414401B (en) 2004-05-28 2009-06-17 Cilag Ag Int Injection device
GB2414406B (en) 2004-05-28 2009-03-18 Cilag Ag Int Injection device
GB2414400B (en) 2004-05-28 2009-01-14 Cilag Ag Int Injection device
GB2414399B (en) 2004-05-28 2008-12-31 Cilag Ag Int Injection device
GB2414775B (en) 2004-05-28 2008-05-21 Cilag Ag Int Releasable coupling and injection device
GB2414402B (en) 2004-05-28 2009-04-22 Cilag Ag Int Injection device
GB2414403B (en) 2004-05-28 2009-01-07 Cilag Ag Int Injection device
US7807647B2 (en) * 2004-06-01 2010-10-05 Pronai Therapeutics, Inc. Methods and compositions for cancer therapy
US8815599B2 (en) 2004-06-01 2014-08-26 Pronai Therapeutics, Inc. Methods and compositions for the inhibition of gene expression
US20050287667A1 (en) * 2004-06-01 2005-12-29 Pronai Therapeutics, Inc. Methods and compositions for the inhibition of gene expression
EP1778877B1 (en) * 2004-07-28 2009-10-21 Canon U.S. Life Sciences, Inc. Methods for monitoring genomic dna of organisms
EP2409713B1 (en) * 2004-08-10 2015-07-22 Genzyme Corporation Oligonucleotides for use in modulating lipoprotein and cholesterol levels in humans
US7759479B1 (en) 2004-09-13 2010-07-20 Isis Pharmaceuticals, Inc. Compositions and their uses directed to Gemin Genes
KR101138862B1 (en) * 2005-02-14 2012-05-14 삼성전자주식회사 A polynucleotide associated with a breast cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a breast cancer using the same
WO2006089192A2 (en) * 2005-02-18 2006-08-24 Canon U.S. Life Sciences, Inc. Devices and methods for identifying genomic dna of organisms
US20070185044A1 (en) * 2005-03-08 2007-08-09 Dobie Kenneth W Modulation of ace2 expression
GB2425062B (en) 2005-04-06 2010-07-21 Cilag Ag Int Injection device
GB2424836B (en) 2005-04-06 2010-09-22 Cilag Ag Int Injection device (bayonet cap removal)
GB2427826B (en) 2005-04-06 2010-08-25 Cilag Ag Int Injection device comprising a locking mechanism associated with integrally formed biasing means
ATE466946T1 (en) 2005-07-06 2010-05-15 Nestec Sa DEHYDRINGENS AND PROMOTORS FROM COFFEE
DE602005018480D1 (en) 2005-08-30 2010-02-04 Cilag Gmbh Int Needle device for a prefilled syringe
AU2014277737B2 (en) * 2005-09-16 2017-02-02 Monsanto Technology Llc Methods for genetic control of insect infestations in plants and compositions thereof
EP2426208B1 (en) 2005-09-16 2016-11-09 Monsanto Technology, LLC Methods for genetic control of insect infestations in plants and compositions thereof
US20110098656A1 (en) 2005-09-27 2011-04-28 Burnell Rosie L Auto-injection device with needle protecting cap having outer and inner sleeves
US8658608B2 (en) * 2005-11-23 2014-02-25 Yale University Modified triple-helix forming oligonucleotides for targeted mutagenesis
JP5122474B2 (en) 2005-12-01 2013-01-16 プロネイ・セラピューティクス・インコーポレイテッド Amphoteric liposome preparation
US7632824B2 (en) * 2006-03-16 2009-12-15 Isis Pharmaceuticals, Inc. Compositions and methods for modulation of Mcl-1 expression
US20090326042A1 (en) 2006-05-05 2009-12-31 Isis Pharmaceuticals, Inc Compounds and methods for modulating expression of crp
US8084734B2 (en) * 2006-05-26 2011-12-27 The George Washington University Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays
GB2438590B (en) 2006-06-01 2011-02-09 Cilag Gmbh Int Injection device
GB2438591B (en) 2006-06-01 2011-07-13 Cilag Gmbh Int Injection device
GB2438593B (en) 2006-06-01 2011-03-30 Cilag Gmbh Int Injection device (cap removal feature)
US7745595B2 (en) * 2006-08-10 2010-06-29 Medical Diagnostic Laboratories, Llc Compositions and methods for detecting Atopobium vaginae
AU2014200037B2 (en) * 2006-10-10 2016-06-02 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
US8188255B2 (en) 2006-10-20 2012-05-29 Exiqon A/S Human microRNAs associated with cancer
WO2008046911A2 (en) * 2006-10-20 2008-04-24 Exiqon A/S Novel human micrornas associated with cancer
RU2015127794A (en) 2007-03-24 2018-12-21 Касл Терапьютикс, ЭлЭлСи Introduction of antisense oligonucleotides complementary to human apolipoprotein B
JP2011502515A (en) * 2007-11-09 2011-01-27 アイシス ファーマシューティカルズ インコーポレイティッド Regulation of factor 9 expression
US20110136115A1 (en) * 2007-11-23 2011-06-09 Epigenomics Ag Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
WO2009069984A2 (en) * 2007-11-30 2009-06-04 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
EP2246422A4 (en) * 2008-01-24 2012-07-25 Nat Inst Of Advanced Ind Scien Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof
US10150990B2 (en) 2008-04-21 2018-12-11 Roche Molecular Systems, Inc. Ribonucleotide tag nucleic acid detection
GB2461086B (en) 2008-06-19 2012-12-05 Cilag Gmbh Int Injection device
GB2461085B (en) 2008-06-19 2012-08-29 Cilag Gmbh Int Injection device
GB2461084B (en) 2008-06-19 2012-09-26 Cilag Gmbh Int Fluid transfer assembly
GB2461087B (en) 2008-06-19 2012-09-26 Cilag Gmbh Int Injection device
GB2461089B (en) 2008-06-19 2012-09-19 Cilag Gmbh Int Injection device
US8110796B2 (en) 2009-01-17 2012-02-07 The George Washington University Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays
GB0901593D0 (en) 2009-01-30 2009-03-11 Touchlight Genetics Ltd Production of closed linear DNA
ES2762610T3 (en) * 2009-02-12 2020-05-25 Curna Inc Treatment of diseases related to brain-derived neurotrophic factor (BDNF) by inhibition of natural antisense transcript for BDNF
CN102439149B (en) * 2009-02-12 2018-01-02 库尔纳公司 By suppressing to treat the related diseases of GDNF for the natural antisense transcript of the glial derived neurotrophic factor (GDNF)
EP2408796B1 (en) 2009-03-16 2020-04-22 Ionis Pharmaceuticals, Inc. Targeting Apolipoprotein B for the reduction of Apolipoprotein C-III
US9490113B2 (en) * 2009-04-07 2016-11-08 The George Washington University Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry
US9234199B2 (en) * 2009-08-05 2016-01-12 Curna, Inc. Treatment of insulin gene (INS) related diseases by inhibition of natural antisense transcript to an insulin gene (INS)
EP2322656A1 (en) * 2009-11-17 2011-05-18 Centre National de la Recherche Scientifique (C.N.R.S) Methods for diagnosing skin diseases
GB201008719D0 (en) * 2010-05-25 2010-07-07 Nat Univ Ireland Diagnostic method
WO2011153514A2 (en) 2010-06-03 2011-12-08 Pharmacyclics, Inc. The use of inhibitors of bruton's tyrosine kinase (btk)
KR102008708B1 (en) * 2010-06-23 2019-08-08 큐알엔에이, 인크. Treatment of sodium channel voltage-gated, alpha subunit (scna) related diseases by inhibition of natural abtisense transcript to scna
WO2012012467A2 (en) 2010-07-19 2012-01-26 Isis Pharmaceuticals, Inc. Modulation of nuclear-retained rna
GB201013153D0 (en) * 2010-08-04 2010-09-22 Touchlight Genetics Ltd Primer for production of closed linear DNA
US9650647B2 (en) 2010-09-06 2017-05-16 Temasek Life Sciences Laboratory Limited Molecular interaction between XA10 and AVRXA10
WO2012038827A2 (en) * 2010-09-20 2012-03-29 Prognomix Inc. Genes linking several complications of type-2 diabetes (t2d)
US8648053B2 (en) * 2010-10-20 2014-02-11 Rosalind Franklin University Of Medicine And Science Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for Usher syndrome
US8916344B2 (en) * 2010-11-15 2014-12-23 Exact Sciences Corporation Methylation assay
WO2012068405A2 (en) * 2010-11-17 2012-05-24 Isis Pharmaceuticals, Inc. Modulation of alpha synuclein expression
AU2013206424B2 (en) * 2010-11-24 2015-09-17 E. I. Du Pont De Nemours And Company Brassica gat event dp-073496-4 and compositions and methods for the identification and/or detection thereof
CA2820067C (en) * 2011-01-12 2019-08-20 Abbott Molecular Inc. Materials and method for detecting cytomegalovirus (cmv)
WO2012106175A1 (en) * 2011-02-02 2012-08-09 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Trrap and grin2a mutations and use thereof for the diagnosis and treatment of melanoma
MY185926A (en) * 2011-07-15 2021-06-14 Acgt Sdn Bhd Ssr markers for plants and uses thereof
AU2012300196B2 (en) * 2011-08-25 2017-12-07 Clinical Genomics Pty. Ltd. DNA methylation in colorectal and breast cancer diagnostic methods
CN103814132B (en) 2011-09-20 2018-06-05 苏州瑞博生物技术有限公司 The antisense of GCGR expression is adjusted
CN103857794B (en) 2011-10-17 2018-03-20 诺维信公司 Alpha-amylase variants and the polynucleotides for encoding them
US9567585B2 (en) * 2011-11-10 2017-02-14 Shire Human Genetic Therapies, Inc. Antisense oligonucleotide modulators of serotonin receptor 2C and uses thereof
MX2014007132A (en) * 2011-12-14 2015-04-16 Staat Der Nederlanden Vert Door De Minister Van Vws Ministerie Van Volksgezondheid Welzijn En Sport Identification of poliovirus strains.
WO2013148260A1 (en) 2012-03-30 2013-10-03 Washington University Methods for modulating tau expression for reducing seizure and modifying a neurodegenerative syndrome
JP2015518713A (en) 2012-05-16 2015-07-06 ラナ セラピューティクス インコーポレイテッド Compositions and methods for modulating UTRN expression
EP2850188A4 (en) 2012-05-16 2016-01-20 Rana Therapeutics Inc Compositions and methods for modulating hemoglobin gene family expression
US10837014B2 (en) 2012-05-16 2020-11-17 Translate Bio Ma, Inc. Compositions and methods for modulating SMN gene family expression
WO2013173598A1 (en) 2012-05-16 2013-11-21 Rana Therapeutics, Inc. Compositions and methods for modulating atp2a2 expression
EA201492116A1 (en) 2012-05-16 2015-05-29 Рана Терапьютикс, Инк. COMPOSITIONS AND METHODS FOR MODULATING THE EXPRESSION OF MECP2
CA2873794A1 (en) 2012-05-16 2013-11-21 Rana Therapeutics Inc. Compositions and methods for modulating smn gene family expression
WO2014018375A1 (en) * 2012-07-23 2014-01-30 Xenon Pharmaceuticals Inc. Cyp8b1 and uses thereof in therapeutic and diagnostic methods
JP6575950B2 (en) 2012-07-24 2019-09-18 ファーマサイクリックス エルエルシー Mutations with resistance to Bruton tyrosine kinase (Btk) inhibitors
WO2014034952A1 (en) * 2012-09-03 2014-03-06 国立大学法人九州大学 Method for predicting efficacy of immunotherapy on cancer
US9175291B2 (en) 2012-10-11 2015-11-03 Isis Pharmaceuticals Inc. Modulation of androgen receptor expression
AU2014223432A1 (en) * 2013-02-28 2015-09-03 Arrowhead Pharmaceuticals, Inc. Organic compositions to treat EPAS1-related diseases
US9359643B2 (en) 2013-03-08 2016-06-07 Progenika Biopharma S.A. Discrimination of blood type variants
EP2971103A1 (en) * 2013-03-14 2016-01-20 Cepheid Methods of detecting lung cancer
BR112015022156A2 (en) 2013-03-14 2017-11-14 Isis Pharmaceuticals Inc compositions and methods for modulating tau expression
MX359794B (en) 2013-03-15 2018-10-10 Intrinsic Lifesciences Llc Anti-hepcidin antibodies and uses thereof.
GB2515039B (en) 2013-06-11 2015-05-27 Cilag Gmbh Int Injection Device
GB2515032A (en) 2013-06-11 2014-12-17 Cilag Gmbh Int Guide for an injection device
GB2515038A (en) 2013-06-11 2014-12-17 Cilag Gmbh Int Injection device
GB2517896B (en) 2013-06-11 2015-07-08 Cilag Gmbh Int Injection device
WO2015188899A1 (en) * 2014-06-12 2015-12-17 Deutsches Krebsforschungszentrum Novel ttv mirna sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention
RU2700244C2 (en) * 2013-07-02 2019-09-13 Ионис Фармасьютикалз, Инк. Modulators of growth hormone receptor
TWI657819B (en) 2013-07-19 2019-05-01 美商Ionis製藥公司 Compositions for modulating tau expression
TW201536329A (en) 2013-08-09 2015-10-01 Isis Pharmaceuticals Inc Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression
GB201315527D0 (en) * 2013-08-30 2013-10-16 Sec Dep For Health The Assay for the detection of infection-causing e.coli strains
US11162096B2 (en) * 2013-10-14 2021-11-02 Ionis Pharmaceuticals, Inc Methods for modulating expression of C9ORF72 antisense transcript
US20160230231A1 (en) * 2013-10-18 2016-08-11 Institut De Cardiologie De Montreal Genotyping tests and methods for evaluating plasma creatine kinase levels
US20160186261A1 (en) * 2013-11-04 2016-06-30 Jose U. Scher Prevotella copri and enhanced susceptibility to arthritis
US9885086B2 (en) * 2014-03-20 2018-02-06 Pharmacyclics Llc Phospholipase C gamma 2 and resistance associated mutations
EP3757214B1 (en) 2014-04-01 2022-06-15 Biogen MA Inc. Compositions for modulating sod-1 expression
JP6667453B2 (en) 2014-05-01 2020-03-18 アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． Compositions and methods for modulating growth hormone receptor expression
CA2956718A1 (en) * 2014-07-31 2016-02-04 Academia Sinica An antagonistic pd-1 aptamer and its applications in cancer therapy related applications
EP3189141B1 (en) * 2014-09-02 2020-06-24 Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft Antisense oligonucleotides targeting 3'utr region of a20
WO2016049036A1 (en) 2014-09-22 2016-03-31 Intrinsic Lifesciences Llc Humanized anti-hepcidin antibodies and uses thereof
EP3221700B1 (en) * 2014-11-18 2022-06-22 Blueprint Medicines Corporation Prkacb fusions
PT3370527T (en) 2015-11-02 2023-11-07 Monsanto Technology Llc Cotton transgenic event mon 88702 and methods for detection and uses thereof
US11136597B2 (en) 2016-02-16 2021-10-05 Yale University Compositions for enhancing targeted gene editing and methods of use thereof
AU2017277666B2 (en) * 2016-06-08 2023-07-27 University Of Iowa Research Foundation Compositions and methods for detecting predisposition to cardiovascular disease
JOP20190065A1 (en) 2016-09-29 2019-03-28 Ionis Pharmaceuticals Inc Compounds and methods for reducing tau expression
AU2017339561B2 (en) 2016-10-07 2024-02-01 Secarna Pharmaceuticals Gmbh & Co. Kg Novel approach for treating cancer
NO344051B1 (en) * 2017-05-04 2019-08-26 Patogen As Novel virus in Fish and Method for detection
KR20200006111A (en) * 2017-05-11 2020-01-17 더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕 Compositions and methods for loading chemical and biological agents / molecules into extracellular vesicles
GB201708617D0 (en) * 2017-05-31 2017-07-12 Blue Genomics Chile Spa Salmonid genetics
GB201711782D0 (en) * 2017-07-21 2017-09-06 Ucl Business Plc Diagnostic and Prognostic methods
TWI809004B (en) 2017-11-09 2023-07-21 美商Ionis製藥公司 Compounds and methods for reducing snca expression
US11447775B2 (en) 2018-01-12 2022-09-20 Bristol-Myers Squibb Company Antisense oligonucleotides targeting alpha-synuclein and uses thereof
JP7239597B2 (en) 2018-03-02 2023-03-14 アイオーニス ファーマシューティカルズ， インコーポレーテッド Regulators of IRF4 expression
JP7275164B2 (en) 2018-04-11 2023-05-17 アイオーニス ファーマシューティカルズ， インコーポレーテッド Regulators of EZH2 expression
MX2020010874A (en) * 2018-04-18 2021-03-25 Pioneer Hi Bred Int Genes, constructs and maize event dp-202216-6.
CN112041447A (en) * 2018-05-18 2020-12-04 奥利通公司 Matrix metalloproteinase-1 antisense oligonucleotides
CN112912500A (en) * 2018-06-05 2021-06-04 豪夫迈·罗氏有限公司 Oligonucleotides for modulating expression of ATXN2
TW202028222A (en) 2018-11-14 2020-08-01 美商Ionis製藥公司 Modulators of foxp3 expression
EP3693465A1 (en) * 2019-02-05 2020-08-12 Pharmaq AS Novel fish coronavirus
EP3927827A4 (en) * 2019-02-22 2023-04-26 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing atxn3 expression
US11286485B2 (en) 2019-04-04 2022-03-29 Hoffmann-La Roche Inc. Oligonucleotides for modulating ATXN2 expression
CN110343764B (en) * 2019-07-22 2020-05-26 武汉艾米森生命科技有限公司 Application of detection reagent for detecting methylation of colorectal cancer related genes and kit
JP7386507B2 (en) 2019-08-02 2023-11-27 国立大学法人信州大学 Muscle differentiation promoting agent, method for promoting muscle differentiation, and oligo DNA for promoting muscle differentiation
BR112022014671A2 (en) * 2020-01-27 2023-02-28 Pioneer Hi Bred Int CORN EVENT DP-056113-9 AND METHODS OF USE THE SAME
US20230119314A1 (en) * 2020-02-17 2023-04-20 Neogen Food Safety Us Holdco Corporation Loop-mediated isothermal amplification primers for vibrio parahaemolyticus detection and uses thereof
DE102020108560B4 (en) * 2020-03-27 2022-03-03 Precision For Medicine Gmbh CBX6 as an epigenetic marker for the identification of immune cells, especially memory B cells
CA3186629A1 (en) * 2020-07-22 2022-01-27 The Florey Institute Of Neuroscience And Mental Health Compositions and methods for treating disorders associated with loss-of-function mutations in scn2a
US20230125137A1 (en) * 2021-07-21 2023-04-27 AcuraStem, Inc. Unc13a antisense oligonucleotides
US11833221B2 (en) 2021-09-01 2023-12-05 Ionis Pharmaceuticals, Inc. Oligomeric compounds for reducing DMPK expression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
JPH09507121A (en) * 1993-10-26 1997-07-22 アフィマックス テクノロジーズ ナームロゼ ベノートスハップ Nucleic acid probe array on biological chip
DE19754482A1 (en) * 1997-11-27 1999-07-01 Epigenomics Gmbh Process for making complex DNA methylation fingerprints

Also Published As

Publication number Publication date
US20040241651A1 (en) 2004-12-02
EP1268856A2 (en) 2003-01-02
WO2001077384A2 (en) 2001-10-18
WO2001077384A3 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
AU2001250572A1 (en) Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations
AU2001238030A1 (en) Detection of single nucleotide polymorphisms
AU2002216035A1 (en) Detection of nucleic acid polymorphisms
AU7612900A (en) Identification of alleles
EP1144682A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU2001245489A1 (en) Human single nucleotide polymorphisms
AU2407600A (en) Microsatellite dna markers and uses thereof
AU2002232419A1 (en) Clinician's assistant system
AU2450001A (en) Detection of single nucleotide polymorphisms
AU2559599A (en) Detection of genetic information
AU1381600A (en) Identification of senv genotypes
AUPP617598A0 (en) Genetic sequence and uses therefor
AU2001251245A1 (en) Haplotypes of the apoa4 gene
AU2001288564A1 (en) 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
AU2001280727A1 (en) Haplotypes of the adrb3 gene
AU2461399A (en) Single nucleotide polymorphisms of the uncoupling protein 2 (ucp2) gene
AU7024500A (en) Essential genes and assays relating thereto
EP1144448A3 (en) Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
AU7500800A (en) Human fmo3 gene mutations and polymorphisms, and uses thereof
AU2002257512A1 (en) Method for detecting single nucleotide polymorphisms (snp's) and point mutations
AU1928801A (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU2001284680A1 (en) Haplotypes of the alas2 gene
AU2002364894A1 (en) Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
AU2002324955A1 (en) Regulatory single nucleotide polymorphisms and methods therefor
AUPP549898A0 (en) Genetic sequences and uses therefor